Modelling human drug abuse and addiction with dedicated small animal positron emission tomography

Neuropharmacology

Volumn 56, Issue SUPPL. 1, 2009, Pages 9-17

  Dalley, Jeffrey W ^a,b,c   Fryer, Tim D ^a,d   Aigbirhio, Franklin I ^a,d   Brichard, Laurent ^a,d   Richards, Hugh K ^a,d   Hong, Young T ^a,d   Baron, Jean Claude ^a,d   Everitt, Barry J ^a,b   Robbins, Trevor W ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UK   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cocaine; DAT; Dopamine; Dopamine receptors; Drug addiction; Impulsivity; Noradrenaline; Nucleus accumbens; Positron emission tomography; Striatum

Indexed keywords

ATOMOXETINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE TRANSPORTER; METHYLPHENIDATE;

ANIMAL MODEL; ATTENTION DEFICIT DISORDER; BRAIN DISEASE; COMORBIDITY; DEPRESSION; DOPAMINE RELEASE; DRUG ABUSE; DRUG DEPENDENCE; IMPULSIVENESS; MENTAL DISEASE; NEUROBIOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REINFORCEMENT; REVIEW; SELF CONTROL;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DISEASE MODELS, ANIMAL; HUMANS; POSITRON-EMISSION TOMOGRAPHY; SUBSTANCE-RELATED DISORDERS;

EID: 58049161600     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.05.029     Document Type: Review

References (139)

1. Adams J.B., Heath A.J., Young S.E., Hewitt J.K., Corley R.P., and Stallings M.C. Relationships between personality and preferred substance and motivations for use among adolescent substance abusers. Am. J. Drug Alcohol Abuse 29 (2003) 691-712
2. Andlin-Sobocki P., and Rehm J. Cost of addiction in Europe. Eur. J. Neurol. 12 Suppl. 1 (2005) 28-33
3. Anthony J.C., and Petronis K.R. Early-onset drug use and risk of later drug problems. Drug Alcohol Depend. 40 (1995) 9-15
4. Arnsten A.F., and Li B.M. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol. Psychiatry 57 (2005) 1377-1384
5. Barbelivien A., Ruotsalainen S., and Sirvio J. Metabolic alterations in the prefrontal and cingulate cortices are related to behavioral deficits in a rodent model of attention-deficit hyperactivity disorder. Cereb. Cortex 11 (2001) 1056-1063
6. Bechara A., Damasio H., and Damasio A.R. Emotion, decision making and the orbitofrontal cortex. Cereb. Cortex 10 (2000) 295-307
7. Blondeau C., and Dellu-Hagedorn F. Dimensional analysis of ADHD subtypes in rats. Biol. Psychiatry 61 (2006) 1340-1350
8. Brickman A.M., Buchsbaum M.S., Shihabuddin L., Hazlett E.A., Borod J.C., and Mohs R.C. Striatal size, glucose metabolic rate, and verbal learning in normal aging. Brain Res. Cogn. Brain Res. 17 (2003) 106-116
9. Buchert R., Thomasius R., Wilke F., Petersen K., Nebeling B., Obrocki J., Schulze O., Schmidt U., and Clausen M. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters. Am. J. Psychiatry 161 (2004) 1181-1189
10. Caballero J., and Nahata M.C. Atomoxetine hydrochloride for the treatment of attention-deficit/hyperactivity disorder. Clin. Ther. 25 (2003) 3065-3083
11. Casey B.J., Castellanos F.X., Giedd J.N., Marsh W.L., Hamburger S.D., Schubert A.B., Vauss Y.C., Vaituzis A.C., Dickstein D.P., Sarfatti S.E., and Rapoport J.L. Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 36 (1997) 374-383
12. Castellanos F.X., and Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat. Rev. Neurosci. 3 (2002) 617-628
13. Castellanos F.X., Giedd J.N., Marsh W.L., Hamburger S.D., Vaituzis A.C., Dickstein D.P., Sarfatti S.E., Vauss Y.C., Snell J.W., Lange N., Kaysen D., Krain A.L., Ritchie G.F., Rajapakse J.C., and Rapoport J.L. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry 53 (1996) 607-616
14. Chakroun N., Doron J., and Swendsen J. [Substance use, affective problems and personality traits: test of two association models.]. Encephale 30 (2004) 564-569
15. 123I]IPT SPET in children with attention deficit hyperactivity disorder. Eur. J. Nucl. Med. Mol. Imaging 30 (2003) 306-311
16. Childress A.R., Mozley P.D., McElgin W., Fitzgerald J., Reivich M., and O'Brien C.P. Limbic activation during cue-induced cocaine craving. Am. J. Psychiatry 156 (1999) 11-18
17. Crabbe J.C., and Cunningham C.L. Trait or state?. Science 317 (2007) 1033-1035 author reply 1033-1035
18. Dalley J.W., Theobald D.E., Eagle D.M., Passetti F., and Robbins T.W. Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex. Neuropsychopharmacology 26 (2002) 716-728
19. Dalley J.W., Cardinal R.N., and Robbins T.W. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci. Biobehav. Rev. 28 (2004) 771-784
20. Dalley J.W., Theobald D.E., Berry D., Milstein J.A., Laane K., Everitt B.J., and Robbins T.W. Cognitive sequelae of intravenous amphetamine self-administration in rats: evidence for selective effects on attentional performance. Neuropsychopharmacology 30 (2005) 525-537
21. Dalley J.W., Fryer T.D., Brichard L., Robinson E.S., Theobald D.E., Laane K., Pena Y., Murphy E.R., Shah Y., Probst K., Abakumova I., Aigbirhio F.I., Richards H.K., Hong Y., Baron J.C., Everitt B.J., and Robbins T.W. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315 (2007) 1267-1270
22. Dalley J.W., Mar A.C., Economidou D., and Robbins T.W. Neurobehavioral mechanisms of impulsivity: Fronto-striatal systems and functional neurochemistry. Pharmacol. Biochem. Behav. 90 (2008) 250-260
23. Dawe S., and Loxton N.J. The role of impulsivity in the development of substance use and eating disorders. Neurosci. Biobehav. Rev. 28 (2004) 343-351
24. Deroche-Gamonet V., Belin D., and Piazza P.V. Evidence for addiction-like behavior in the rat. Science 305 (2004) 1014-1017
25. Di Chiara G., and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 5274-5278
26. Diergaarde L., Pattij T., Poortvliet I., Hogenboom F., de Vries W., Schoffelmeer A.N., and De Vries T.J. Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats. Biol. Psychiatry 63 (2008) 301-308
27. Ding Y.S., Lin K.S., and Logan J. PET imaging of norepinephrine transporters. Curr. Pharm. Des. 12 (2006) 3831-3845
28. Dom G., Sabbe B., Hulstijn W., and van den Brink W. Substance use disorders and the orbitofrontal cortex: systematic review of behavioural decision-making and neuroimaging studies. Br. J. Psychiatry 187 (2005) 209-220
29. Dougherty D.D., Bonab A.A., Spencer T.J., Rauch S.L., Madras B.K., and Fischman A.J. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354 (1999) 2132-2133
30. Dresel S., Krause J., Krause K.H., LaFougere C., Brinkbaumer K., Kung H.F., Hahn K., and Tatsch K. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur. J. Nucl. Med. 27 (2000) 1518-1524
31. van Dyck C.H., Quinlan D.M., Cretella L.M., Staley J.K., Malison R.T., Baldwin R.M., Seibyl J.P., and Innis R.B. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. Am. J. Psychiatry 159 (2002) 309-312
32. Elia J., Ambrosini P.J., and Rapoport J.L. Treatment of attention-deficit-hyperactivity disorder. N. Engl. J. Med. 340 (1999) 780-788
33. Ernst M., Zametkin A.J., Matochik J.A., Jons P.H., and Cohen R.M. DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study. J. Neurosci. 18 (1998) 5901-5907
34. Ernst M., Zametkin A.J., Phillips R.L., and Cohen R.M. Age-related changes in brain glucose metabolism in adults with attention-deficit/hyperactivity disorder and control subjects. J. Neuropsychiatry Clin. Neurosci. 10 (1998) 168-177
35. 18F]DOPA accumulation in children with attention deficit hyperactivity disorder. Am. J. Psychiatry 156 (1999) 1209-1215
36. Everitt B.J., and Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8 (2005) 1481-1489
37. Everitt B.J., Hutcheson D.M., Ersche K.D., Pelloux Y., Dalley J.W., and Robbins T.W. The orbital prefrontal cortex and drug addiction in laboratory animals and humans. Ann. N.Y. Acad. Sci. 1121 (2007) 576-597
38. Faraone S.V., and Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biol. Psychiatry 44 (1998) 951-958
39. Fone K.C., and Nutt D.J. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder. Curr. Opin. Pharmacol. 5 (2005) 87-93
40. Forssberg H., Fernell E., Waters S., Waters N., and Tedroff J. Altered pattern of brain dopamine synthesis in male adolescents with attention deficit hyperactivity disorder. Behav. Brain Funct. 2 (2006) 40
41. Franklin T.R., Acton P.D., Maldjian J.A., Gray J.D., Croft J.R., Dackis C.A., O'Brien C.P., and Childress A.R. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol. Psychiatry 51 (2002) 134-142
42. Friedman H.R., and Goldman-Rakic P.S. Coactivation of prefrontal cortex and inferior parietal cortex in working memory tasks revealed by 2DG functional mapping in the rhesus monkey. J. Neurosci. 14 (1994) 2775-2788
43. Garavan H., Pankiewicz J., Bloom A., Cho J.K., Sperry L., Ross T.J., Salmeron B.J., Risinger R., Kelley D., and Stein E.A. Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am. J. Psychiatry 157 (2000) 1789-1798
44. Ginovart N., Farde L., Halldin C., and Swahn C.G. Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates. Synapse 31 (1999) 154-162
45. Goldstein R.Z., Tomasi D., Rajaram S., Cottone L.A., Zhang L., Maloney T., Telang F., Alia-Klein N., and Volkow N.D. Role of the anterior cingulate and medial orbitofrontal cortex in processing drug cues in cocaine addiction. Neuroscience 144 (2007) 1153-1159
46. GottesmanGould II T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 160 (2003) 636-645
47. Grant B.F., and Dawson D.A. Age of onset of drug use and its association with DSM-IV drug abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. J. Subst. Abuse 10 (1998) 163-173
48. Grant S., London E.D., Newlin D.B., Villemagne V.L., Liu X., Contoreggi C., Phillips R.L., Kimes A.S., and Margolin A. Activation of memory circuits during cue-elicited cocaine craving. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 12040-12045
49. Gunn R.N., Lammertsma A.A., Hume S.P., and Cunningham V.J. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6 (1997) 279-287
50. Gustafsson P., Thernlund G., Ryding E., Rosen I., and Cederblad M. Associations between cerebral blood-flow measured by single photon emission computed tomography (SPECT), electro-encephalogram (EEG), behaviour symptoms, cognition and neurological soft signs in children with attention-deficit hyperactivity disorder (ADHD). Acta Paediatr. 89 (2000) 830-835
51. Heinz A., Siessmeier T., Wrase J., Hermann D., Klein S., Grusser S.M., Flor H., Braus D.F., Buchholz H.G., Grunder G., Schreckenberger M., Smolka M.N., Rosch F., Mann K., and Bartenstein P. Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. Am. J. Psychiatry 161 (2004) 1783-1789
52. Hester R., and Garavan H. Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J. Neurosci. 24 (2004) 11017-11022
53. Hosoi R., Matsumura A., Mizokawa S., Tanaka M., Nakamura F., Kobayashi K., Watanabe Y., and Inoue O. MicroPET detection of enhanced 18F-FDG utilization by PKA inhibitor in awake rat brain. Brain Res. 1039 (2005) 199-202
54. Howell L.L., Hoffman J.M., Votaw J.R., Landrum A.M., and Jordan J.F. An apparatus and behavioral training protocol to conduct positron emission tomography (PET) neuroimaging in conscious rhesus monkeys. J. Neurosci. Methods 106 (2001) 161-169
55. Howell L.L., Hoffman J.M., Votaw J.R., Landrum A.M., Wilcox K.M., and Lindsey K.P. Cocaine-induced brain activation determined by positron emission tomography neuroimaging in conscious rhesus monkeys. Psychopharmacology (Berl) 159 (2002) 154-160
56. Hume S.P., Myers R., Bloomfield P.M., Opacka-Juffry J., Cremer J.E., Ahier R.G., Luthra S.K., Brooks D.J., and Lammertsma A.A. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse 12 (1992) 47-54
57. Ilgin N., Senol S., Gucuyener K., Gokcora N., and Sener S. Is increased D2 receptor availability associated with response to stimulant medication in ADHD. Dev. Med. Child Neurol. 43 (2001) 755-760
58. Jakobsen S., Pedersen K., Smith D.F., Jensen S.B., Munk O.L., and Cumming P. Detection of alpha2-adrenergic receptors in brain of living pig with 11C-yohimbine. J. Nucl. Med. 47 (2006) 2008-2015
59. Jentsch J.D., and Taylor J.R. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 146 (1999) 373-390
60. Jonsson E.G., Nothen M.M., Grunhage F., Farde L., Nakashima Y., Propping P., and Sedvall G.C. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol. Psychiatry 4 (1999) 290-296
61. Jucaite A., Fernell E., Halldin C., Forssberg H., and Farde L. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol. Psychiatry 57 (2005) 229-238
62. Kawachi T., Ishii K., Sakamoto S., Matsui M., Mori T., and Sasaki M. Gender differences in cerebral glucose metabolism: a PET study. J. Neurol. Sci. 199 (2002) 79-83
63. Kerns J.G., Cohen J.D., MacDonald III A.W., Cho R.Y., Stenger V.A., and Carter C.S. Anterior cingulate conflict monitoring and adjustments in control. Science 303 (2004) 1023-1026
64. Kirby K.N., and Petry N.M. Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non-drug-using controls. Addiction 99 (2004) 461-471
65. Krause K.H., Dresel S.H., Krause J., Kung H.F., and Tatsch K. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci. Lett. 285 (2000) 107-110
66. Kreek M.J., Nielsen D.A., Butelman E.R., and LaForge K.S. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat. Neurosci. 8 (2005) 1450-1457
67. Kuczenski R., and Segal D.S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J. Neurochem. 68 (1997) 2032-2037
68. Kutcher S., Aman M., Brooks S.J., Buitelaar J., van Daalen E., Fegert J., Findling R.L., Fisman S., Greenhill L.L., Huss M., Kusumakar V., Pine D., Taylor E., and Tyano S. International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions. Eur. Neuropsychopharmacol. 14 (2004) 11-28
69. Levin F.R., and Kleber H.D. Attention-deficit hyperactivity disorder and substance abuse: relationships and implications for treatment. Harv. Rev. Psychiatry 2 (1995) 246-258
70. Lyvers M. "Loss of control" in alcoholism and drug addiction: a neuroscientific interpretation. Exp. Clin. Psychopharmacol. 8 (2000) 225-249
71. Martinez D., Broft A., Foltin R.W., Slifstein M., Hwang D.R., Huang Y., Perez A., Frankle W.G., Cooper T., Kleber H.D., Fischman M.W., and Laruelle M. Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology 29 (2004) 1190-1202
72. Martinez D., Narendran R., Foltin R.W., Slifstein M., Hwang D.R., Broft A., Huang Y., Cooper T.B., Fischman M.W., Kleber H.D., and Laruelle M. Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am. J. Psychiatry 164 (2007) 622-629
73. McCann U.D., Szabo Z., Scheffel U., Dannals R.F., and Ricaurte G.A. Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet 352 (1998) 1433-1437
74. Mirrione M.M., Schiffer W.K., Siddiq M., Dewey S.L., and Tsirka S.E. PET imaging of glucose metabolism in a mouse model of temporal lobe epilepsy. Synapse 59 (2006) 119-121
75. Morgan D., Grant K.A., Gage H.D., Mach R.H., Kaplan J.R., Prioleau O., Nader S.H., Buchheimer N., Ehrenkaufer R.L., and Nader M.A. Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat. Neurosci. 5 (2002) 169-174
76. Mukherjee J., Yang Z.Y., Brown T., Lew R., Wernick M., Ouyang X., Yasillo N., Chen C.T., Mintzer R., and Cooper M. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride. Nucl. Med. Biol. 26 (1999) 519-527
77. Mukherjee J., Christian B.T., Narayanan T.K., Shi B., and Collins D. Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET. Brain Res. 1032 (2005) 77-84
78. Nader M.A., Morgan D., Gage H.D., Nader S.H., Calhoun T.L., Buchheimer N., Ehrenkaufer R., and Mach R.H. PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat. Neurosci. 9 (2006) 1050-1056
79. Nigg J.T., Wong M.M., Martel M.M., Jester J.M., Puttler L.I., Glass J.M., Adams K.M., Fitzgerald H.E., and Zucker R.A. Poor response inhibition as a predictor of problem drinking and illicit drug use in adolescents at risk for alcoholism and other substance use disorders. J. Am. Acad. Child Adolesc. Psychiatry 45 (2006) 468-475
80. O'Hearn E., Battaglia G., De Souza E.B., Kuhar M.J., and Molliver M.E. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J. Neurosci. 8 (1988) 2788-2803
81. Oswald L.M., Wong D.F., McCaul M., Zhou Y., Kuwabara H., Choi L., Brasic J., and Wand G.S. Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine. Neuropsychopharmacology 30 (2005) 821-832
82. Packard M.G., and Knowlton B.J. Learning and memory functions of the Basal Ganglia. Annu. Rev. Neurosci. 25 (2002) 563-593
83. Pelloux Y., Everitt B.J., and Dickinson A. Compulsive drug seeking by rats under punishment: effects of drug taking history. Psychopharmacology (Berl) 194 (2007) 127-137
84. Perry J.L., Larson E.B., German J.P., Madden G.J., and Carroll M.E. Impulsivity (delay discounting) as a predictor of acquisition of IV cocaine self-administration in female rats. Psychopharmacology (Berl) 178 (2005) 193-201
85. Piazza P.V., Rouge-Pont F., Deminiere J.M., Kharoubi M., Le Moal M., and Simon H. Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Res. 567 (1991) 169-174
86. Pontieri F.E., Tanda G., and Di Chiara G. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 12304-12308
87. Porrino L.J., Lyons D., Smith H.R., Daunais J.B., and Nader M.A. Cocaine self-administration produces a progressive involvement of limbic, association, and sensorimotor striatal domains. J. Neurosci. 24 (2004) 3554-3562
88. Poulos C.X., Le A.D., and Parker J.L. Impulsivity predicts individual susceptibility to high levels of alcohol self-administration. Behav. Pharmacol. 6 (1995) 810-814
89. Puumala T., Ruotsalainen S., Jakala P., Koivisto E., Riekkinen Jr. P., and Sirvio J. Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder. Neurobiol. Learn. Mem. 66 (1996) 198-211
90. Rauchs G., Blaizot X., Giffard C., Baron J.C., Insausti R., and Chavoix C. Imaging visual recognition memory network by PET in the baboon: perirhinal cortex heterogeneity and plasticity after perirhinal lesion. J. Cereb. Blood Flow Metab 26 (2006) 301-309
91. Ricaurte G.A., Martello A.L., Katz J.L., and Martello M.B. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. J. Pharmacol. Exp. Ther. 261 (1992) 616-622
92. Robbins T.W. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163 (2002) 362-380
93. Roberts D.C., Corcoran M.E., and Fibiger H.C. On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol. Biochem. Behav. 6 (1977) 615-620
94. Robinson T.E., and Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47 Suppl. 1 (2004) 33-46
95. Robinson E.S., Eagle D.M., Mar A.C., Bari A., Banerjee G., Jiang X., Dalley J.W., and Robbins T.W. Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 33 (2008) 1028-1037
96. Rosa-Neto P., Lou H.C., Cumming P., Pryds O., Karrebaek H., Lunding J., and Gjedde A. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. Neuroimage 25 (2005) 868-876
97. Rubia K., Overmeyer S., Taylor E., Brammer M., Williams S.C., Simmons A., and Bullmore E.T. Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. Am. J. Psychiatry 156 (1999) 891-896
98. Russell V., de Villiers A., Sagvolden T., Lamm M., and Taljaard J. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder-the spontaneously hypertensive rat. Brain Res. 676 (1995) 343-351
99. Russell V.A., Sagvolden T., and Johansen E.B. Animal models of attention-deficit hyperactivity disorder. Behav. Brain Funct. 1 (2005) 9
100. Sagvolden T., Metzger M.A., Schiorbeck H.K., Rugland A.L., Spinnangr I., and Sagvolden G. The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants. Behav. Neural Biol. 58 (1992) 103-112
101. Scahill L., Chappell P.B., Kim Y.S., Schultz R.T., Katsovich L., Shepherd E., Arnsten A.F., Cohen D.J., and Leckman J.F. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am. J. Psychiatry 158 (2001) 1067-1074
102. Schoenbaum G., Roesch M.R., and Stalnaker T.A. Orbitofrontal cortex, decision-making and drug addiction. Trends Neurosci. 29 (2006) 116-124
103. 11C]MeNER. Nucl. Med. Biol. 30 (2003) 707-714
104. Schou M., Halldin C., Sovago J., Pike V.W., Hall H., Gulyas B., Mozley P.D., Dobson D., Shchukin E., Innis R.B., and Farde L. PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain. Synapse 53 (2004) 57-67
105. 18F]FMeNER-D2. Psychopharmacology (Berl) 188 (2006) 119-127
106. Sher K.J., Bartholow B.D., and Wood M.D. Personality and substance use disorders: a prospective study. J. Consult. Clin. Psychol. 68 (2000) 818-829
107. Siessmeier T., Zhou Y., Buchholz H.G., Landvogt C., Vernaleken I., Piel M., Schirrmacher R., Rosch F., Schreckenberger M., Wong D.F., Cumming P., Grunder G., and Bartenstein P. Parametric mapping of binding in human brain of D2 receptor ligands of different affinities. J. Nucl. Med. 46 (2005) 964-972
108. Smith A.J., Becker S., and Kapur S. A computational model of the functional role of the ventral-striatal D2 receptor in the expression of previously acquired behaviors. Neural Comput. 17 (2005) 361-395
109. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28 (1977) 897-916
110. Solanto M.V. Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav. Brain Res. 130 (2002) 65-71
111. Spencer T.J., Biederman J., Madras B.K., Dougherty D.D., Bonab A.A., Livni E., Meltzer P.C., Martin J., Rauch S., and Fischman A.J. Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane. Biol. Psychiatry 62 (2007) 1059-1061
112. Spencer T.J., Biederman J., Madras B.K., Faraone S.V., Dougherty D.D., Bonab A.A., and Fischman A.J. In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter. Biol. Psychiatry 57 (2005) 1293-1300
113. Swanson J.M., Sergeant J.A., Taylor E., Sonuga-Barke E.J., Jensen P.S., and Cantwell D.P. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351 (1998) 429-433
114. Thomason C., and Michelson D. Atomoxetine-treatment of attention deficit hyperactivity disorder: beyond stimulants. Drugs Today (Barc) 40 (2004) 465-473
115. Todd R.D., and Botteron K.N. Is attention-deficit/hyperactivity disorder an energy deficiency syndrome?. Biol. Psychiatry 50 (2001) 151-158
116. Tsukada H., Kreuter J., Maggos C.E., Unterwald E.M., Kakiuchi T., Nishiyama S., Futatsubashi M., and Kreek M.J. Effects of binge pattern cocaine administration on dopamine D1 and D2 receptors in the rat brain: an in vivo study using positron emission tomography. J. Neurosci. 16 (1996) 7670-7677
117. 11C]raclopride?: PET studies combined with microdialysis in conscious monkeys. Brain Res. 841 (1999) 160-169
118. Uhl G. Premature poking: impulsivity, cocaine and dopamine. Nat. Med. 13 (2007) 413-414
119. Vaidya C.J., Austin G., Kirkorian G., Ridlehuber H.W., Desmond J.E., Glover G.H., and Gabrieli J.D. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 14494-14499
120. 11C]R107474, a new radiolabeled alpha2-adrenoceptor antagonist. Bioorg. Med. Chem. 14 (2006) 4526-4534
121. Vanderschuren L.J., Di Ciano P., and Everitt B.J. Involvement of the dorsal striatum in cue-controlled cocaine seeking. J. Neurosci. 25 (2005) 8665-8670
122. Volkow N.D., and Wise R.A. How can drug addiction help us understand obesity?. Nat. Neurosci. 8 (2005) 555-560
123. Volkow N.D., Fowler J.S., Wang G.J., Hitzemann R., Logan J., Schlyer D.J., Dewey S.L., and Wolf A.P. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14 (1993) 169-177
124. Volkow N.D., Wang G.J., Fischman M.W., Foltin R.W., Fowler J.S., Abumrad N.N., Vitkun S., Logan J., Gatley S.J., Pappas N., Hitzemann R., and Shea C.E. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386 (1997) 827-830
125. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Hitzemann R., Chen A.D., Dewey S.L., and Pappas N. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386 (1997) 830-833
126. Volkow N.D., Wang G.J., Fowler J.S., Gatley S.J., Logan J., Ding Y.S., Dewey S.L., Hitzemann R., Gifford A.N., and Pappas N.R. Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high". J. Pharmacol. Exp. Ther. 288 (1999) 14-20
127. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Gifford A., Hitzemann R., Ding Y.S., and Pappas N. Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am. J. Psychiatry 156 (1999) 1440-1443
128. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Ding Y.S., Sedler M., Logan J., Franceschi D., Gatley J., Hitzemann R., Gifford A., Wong C., and Pappas N. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am. J. Psychiatry 158 (2001) 2015-2021
129. Volkow N.D., Fowler J.S., Wang G.J., and Goldstein R.Z. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol. Learn. Mem. 78 (2002) 610-624
130. Volkow N.D., Wang G.J., Begleiter H., Porjesz B., Fowler J.S., Telang F., Wong C., Ma Y., Logan J., Goldstein R., Alexoff D., and Thanos P.K. High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Arch. Gen. Psychiatry 63 (2006) 999-1008
131. Volkow N.D., Wang G.J., Telang F., Fowler J.S., Logan J., Childress A.R., Jayne M., Ma Y., and Wong C. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J. Neurosci. 26 (2006) 6583-6588
132. Volkow N.D., Wang G.J., Newcorn J., Fowler J.S., Telang F., Solanto M.V., Logan J., Wong C., Ma Y., Swanson J.M., Schulz K., and Pradhan K. Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage 34 (2007) 1182-1190
133. Winstanley C.A., Eagle D.M., and Robbins T.W. Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin. Psychol. Rev. 26 (2006) 379-395
134. Wise R.A., and Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94 (1987) 469-492
135. Wong D.F., Kuwabara H., Schretlen D.J., Bonson K.R., Zhou Y., Nandi A., Brasic J.R., Kimes A.S., Maris M.A., Kumar A., Contoreggi C., Links J., Ernst M., Rousset O., Zukin S., Grace A.A., Lee J.S., Rohde C., Jasinski D.R., Gjedde A., and London E.D. Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology 31 (2006) 2716-2727
136. Wong M.M., Nigg J.T., Zucker R.A., Puttler L.I., Fitzgerald H.E., Jester J.M., Glass J.M., and Adams K. Behavioral control and resiliency in the onset of alcohol and illicit drug use: a prospective study from preschool to adolescence. Child Dev. 77 (2006) 1016-1033
137. Yin H.H., Knowlton B.J., and Balleine B.W. Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning. Eur. J. Neurosci. 19 (2004) 181-189
138. Zametkin A.J., Nordahl T.E., Gross M., King A.C., Semple W.E., Rumsey J., Hamburger S., and Cohen R.M. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N. Engl. J. Med. 323 (1990) 1361-1366
139. Zocchi A., Girlanda E., Varnier G., Sartori I., Zanetti L., Wildish G.A., Lennon M., Mugnaini M., and Heidbreder C.A. Dopamine responsiveness to drugs of abuse: a shell-core investigation in the nucleus accumbens of the mouse. Synapse 50 (2003) 293-302